APA
CNCR

American Portfolios Advisors’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History

American Portfolios Advisors’s Portfolio CNCR Stock Details CNCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$57.7K Sell
3,938
-742
-16% -$12K ﹤0.01% 1616
2022
Q2 		$71.1K Hold
4,680
– – ﹤0.01% 1577
2022
Q1 		$84.2K Sell
4,680
-137
-3% -$2.6K ﹤0.01% 1607
2021
Q4 		$115K Sell
4,817
-890
-16% -$24.7K ﹤0.01% 1446
2021
Q3 		$173K Sell
5,707
-365
-6% -$11K 0.01% 1181
2021
Q2 		$194K Hold
6,072
– – 0.01% 1114
2021
Q1 		$182K Buy
6,072
+23
+0.4% +$749 0.01% 1066
2020
Q4 		$192K Sell
6,049
-40
-0.7% -$1.2K 0.01% 897
2020
Q3 		$167K Hold
6,089
– – 0.01% 867
2020
Q2 		$165K Sell
6,089
-216
-3% -$5.3K 0.01% 805
2020
Q1 		$123K Sell
6,305
-1,419
-18% -$30.6K 0.01% 823
2019
Q4 		$181K Sell
7,724
-3,787
-33% -$80.2K 0.01% 774
2019
Q3 		$216K Sell
11,511
-99
-0.9% -$2.01K 0.02% 686
2019
Q2 		$245K Buy
11,610
+246
+2% +$5.07K 0.02% 629
2019
Q1 		$239K Sell
11,364
-69
-0.6% -$1.45K 0.02% 584
2018
Q4 		$216K Sell
11,433
-3,465
-23% -$72.2K 0.03% 491
2018
Q3 		$370K Buy
14,898
+23
+0.2% +$565 0.04% 398
2018
Q2 		$359K Buy
14,875
+4,991
+50% +$135K 0.05% 363
2018
Q1 		$287K Sell
9,884
-72
-0.7% -$2.04K 0.04% 392
2017
Q4 		$237K Buy
+9,956
New +$252K 0.04% 444

Other funds holding CNCR

BL
BCWM LLC Overland Park, Kansas $353M AUM 20.1% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

American Portfolios Advisors's CNCR Position: Q3 2022 in Review

American Portfolios Advisors reduced its ETF Series Solutions Trust Range Cancer Therapeutics ETF (CNCR) stake by 16% in Q3 2022, selling an estimated $12K and leaving 3,938 shares worth $57.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1616.

American Portfolios Advisors first reported a position in CNCR in Q4 2017 and has held it in 20 quarters since. The position peaked at $370K in Q3 2018. 19 funds tracked by Wall St. Rank hold CNCR as of Q3 2022.

  • American Portfolios Advisors held 3,938 shares of ETF Series Solutions Trust Range Cancer Therapeutics ETF worth $57.7K as of Q3 2022.
  • American Portfolios Advisors sold 742 ETF Series Solutions Trust Range Cancer Therapeutics ETF shares in Q3 2022, an estimated $12K.
  • ETF Series Solutions Trust Range Cancer Therapeutics ETF made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #1616 holding.
  • American Portfolios Advisors first reported a position in ETF Series Solutions Trust Range Cancer Therapeutics ETF in Q4 2017 and has held it in 20 quarters since.
  • American Portfolios Advisors's ETF Series Solutions Trust Range Cancer Therapeutics ETF position peaked at $370K in Q3 2018.
  • 19 funds tracked by Wall St. Rank held ETF Series Solutions Trust Range Cancer Therapeutics ETF as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.